Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
Amir Abbas Tahami MonfaredAli TafazzoliWeicheng YeAmeya ChavanQuanwu ZhangPublished in: Neurology and therapy (2022)
The model results demonstrate the potential clinical value of lecanemab for patients with early AD and how it can slow the rate of disease progression and reduce the lifetime probability for institutionalized care.